Join
Live feed
·
PRReleasevia Quantisnow
Cortexyme Inc. logo

Cortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588

ByQuantisnow·Wall Street's wire, on your screen.
CRTX· Cortexyme Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRTX (Cortexyme Inc.) and more on Quantisnow.